Phase 1b/2 Study of Oprozomib in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Advanced Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- NA
Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase I, Open Label, Non Randomized, Multicenter, Dose Escalation Clinical Study to Investigate Safety and Tolerability of OPB(Otsuka Pharmaceutical Biwa)-111077 in Subjects With Advanced HCC(Hepatocellular Carcinoma)
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced HCC
- Status
- COMPLETED
- Phase
- PHASE2
Study of ARQ 197 in Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib Plus Tegafur-uracil (UFT) Versus Sorafenib as First Line Systemic Treatment for Patients With Advanced Stage HCC, Unresectable & Not Eligible for Local Ablation and/or TACE
- Status
- TERMINATED
- Phase
- PHASE2
Trial of Palliative Chemotherapy With TS-1 and Oxaliplatin for Patients With Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Apatinib in Patients With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Siliphos in Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of TAC-101 in Combination With TACE Versus TACE Alone in Asian Patients With Advanced Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 2 Study of TAC-101 Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone in Japanese Patients With Advanced Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2